Bovine Lactoferricin Inhibits Basic Fibroblast Growth Factor- and Vascular Endothelial Growth Factor165-Induced Angiogenesis by Competing for Heparin-Like Binding Sites on Endothelial Cells
Authors:
- Daniel SmythDSDaniel Smyth
- Jean MarshallJMJean Marshall
- David W. HoskinDHDavid W. Hoskin
- 1 November 2006
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 169 (5) , 1753-1766
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Heparin Regulates Vascular Endothelial Growth Factor165-dependent Mitogenic Activity, Tube Formation, and Its Receptor Phosphorylation of Human Endothelial CellsJournal of Biological Chemistry, 2005
- Use of angiogenesis inhibitors in tumour treatmentEuropean Journal of Cancer, 2005
- Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell linesMolecular Cancer Therapeutics, 2005
- Orally administered bovine lactoferrin systemically inhibits VEGF165‐mediated angiogenesis in the ratInternational Journal of Cancer, 2001
- The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.Journal of Clinical Investigation, 1998
- Three-Dimensional Solution Structure of Lactoferricin B, an Antimicrobial Peptide Derived from Bovine LactoferrinBiochemistry, 1998
- Bovine Lactoferrin and Lactoferricin, a Peptide Derived from Bovine Lactoferrin, Inhibit Tumor Metastasis in MiceJapanese Journal of Cancer Research, 1997
- Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N ‐terminal region of bovine lactoferrinJournal of Applied Bacteriology, 1992
- Extracellular matrix‐resident basic fibroblast growth factor: Implication for the control of angiogenesisJournal of Cellular Biochemistry, 1991
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973